BABA vs BFAM

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

BFAM exhibits a mixed financial profile with a weak Piotroski F-Score of 4/9 indicating marginal financial health, and no available Altman Z-Score limits distress risk assessment. Despite strong recent earnings growth (YoY EPS +45.7%) and solid revenue momentum (11.6% growth), the company faces significant liquidity concerns with a current ratio of 0.54 and quick ratio of 0.43, suggesting near-term solvency risks. Valuation is stretched relative to Graham’s defensive standard ($44.17 vs current $93.43), though growth investors may justify the premium given robust earnings progression and analyst target of $127.33. Insider selling activity and bearish technical trend counterbalance strong profitability metrics like ROE of 14.19% and improving margins.